MedTrace Logo

Triggering Oocyte Maturation in Normoresponders Using Double Trigger or HCG Trigger

NCT06146413 · Status: NOT_YET_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2023-11-29

No results posted yet for this study

Summary

The aim of this study is to compare the efficacy double trigger \[ co-administration of GnRH agonist with HCG 40 and 34 h prior to ovum pick-up, respectively\] with HCG trigger in inducing oocyte maturation.

Conditions

Interventions

DRUG

Double trigger

GnRH agonist ( Triptorelin ) ( 0.2 mg / S.C ) and hCG ( 10000 IU) are administered 40 and 34 h before ovum pick-up

DRUG

HCG trigger

hCG ( 10000 IU) is administered 36 h before ovum pick-up

Sponsors & Collaborators

  • Bedaya Hospital

    lead OTHER

Principal Investigators

  • Ismail Aboul Foutouh, Prof. · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-30
Primary Completion
2025-03-30
Completion
2025-12-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06146413 on ClinicalTrials.gov